Source link : https://www.newshealth.biz/health-news/investigative-treatments-for-moderate-to-severe-psoriasis-reviewed/
NEW YORK — No fewer than four investigative therapies, ranging from an oral interleukin-23 receptor antagonist to oral tyrosine kinase inhibitors and a long-acting biologic, have the potential to change how dermatologists treat moderate to severe psoriasis, Bruce R. Strober, MD, said at the New York University (NYU) Langone Advanced Seminar in Psoriasis and Psoriatic […]
Author : News Health
Publish date : 2025-01-29 10:15:41
Copyright for syndicated content belongs to the linked Source.